|
RTCD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.746500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.148600E-01 |
| Normal-vs-Stage2 |
4.457800E-01 |
| Normal-vs-Stage3 |
4.584400E-02 |
| Normal-vs-Stage4 |
6.447600E-02 |
| Stage1-vs-Stage2 |
8.973800E-01 |
| Stage1-vs-Stage3 |
1.832980E-01 |
| Stage1-vs-Stage4 |
2.986600E-01 |
| Stage2-vs-Stage3 |
3.393200E-01 |
| Stage2-vs-Stage4 |
4.048200E-01 |
| Stage3-vs-Stage4 |
8.906600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.736300E-02 |
| Normal-vs-AfricanAmerican |
3.109600E-02 |
| Normal-vs-Asian |
7.385600E-01 |
| Caucasian-vs-AfricanAmerican |
2.487400E-01 |
| Caucasian-vs-Asian |
3.459400E-01 |
| AfricanAmerican-vs-Asian |
1.517230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.773600E-02 |
| Normal-vs-Female |
5.311200E-01 |
| Male-vs-Female |
2.812500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.204970E-01 |
| Normal-vs-Age(41-60Yrs) |
1.525580E-01 |
| Normal-vs-Age(61-80Yrs) |
1.601850E-01 |
| Normal-vs-Age(81-100Yrs) |
1.804190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.607400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.433800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.663400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.526000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.440200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.763800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.548000E-01 |
| Normal-vs-Grade 2 |
5.588600E-01 |
| Normal-vs-Grade 3 |
1.172270E-02 |
| Normal-vs-Grade 4 |
2.663900E-02 |
| Grade 1-vs-Grade 2 |
3.771800E-01 |
| Grade 1-vs-Grade 3 |
4.803500E-02 |
| Grade 1-vs-Grade 4 |
5.557800E-02 |
| Grade 2-vs-Grade 3 |
9.281400E-03 |
| Grade 2-vs-Grade 4 |
3.694200E-02 |
| Grade 3-vs-Grade 4 |
7.473800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.370000E-01 |
| Normal-vs-ccB subtype |
4.424800E-03 |
| ccA subtype-vs-ccB subtype |
7.34030000004715E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.519000E-01 |
| Normal-vs-N1 |
1.028160E-01 |
| N0-vs-N1 |
2.429200E-01 |
|
|
